Publications by authors named "Ryo Horii"

Background: Temozolomide (TMZ) is an alkylating agent used to treat glioblastoma. However, the pharmacokinetics of TMZ to establish a treatment strategy for patients undergoing hemodialysis (HD) remain unclear. In this case report, we evaluated the pharmacokinetics and HD removal rate of TMZ in a patient with glioblastoma undergoing HD to determine optimal dosing of TMZ.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the safety and effectiveness of the Center Wire and anchor wire technique for delivering devices to treat intracranial aneurysms, which are often challenging due to complications like vessel perforation and difficult anatomy.
  • - Ten patients with aneurysms participated, and the anchor wire technique was successfully applied, with only one minor device-related incident (asymptomatic vasospasm) reported.
  • - Overall, the results indicate that the Center Wire is safe and effective for neuroendovascular treatment, with no serious complications linked to the device during this initial human trial.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the safety and efficacy of a new device called the Stabilizer for navigating large inner diameter microcatheters during intracranial treatments, as traditional methods can risk vessel damage.
  • Conducted as a first-in-human trial with five female patients aged 41 to 70, the procedure involved treating various types of aneurysms using the Stabilizer device without any adverse events.
  • The initial findings indicate that the Stabilizer device is a safe option for neuro-endovascular therapies, successfully allowing the microcatheter navigation needed for effective treatment of intracranial lesions.
View Article and Find Full Text PDF

A persistent primitive trigeminal artery (PPTA) is a vessel remnant of carotid-vertebrobasilar anastomosis. The aneurysm at the bifurcation of the internal carotid artery (ICA) and PPTA tends to have a broad neck with the branch incorporated into the sac. Because PPTA supplies to the posterior circulation and branches off direct pontine perforators, PPTA preservation should always be considered when treating PPTA aneurysms to avoid ischemic complications.

View Article and Find Full Text PDF

Vasospasm, initial neurological damage, rebleeding, and periprocedural complications are associated prognostic factors for clinical outcomes after aneurysmal subarachnoid hemorrhage (SAH). In this study, factors related to delayed ischemic neurological deficit (DIND) are evaluated using data from our institute for the last 18 years. Data from 2001 to 2018 of patients with aneurysmal SAH who underwent surgical clipping (SC) or endovascular coiling (EC) within 7 days of onset were retrospectively analyzed.

View Article and Find Full Text PDF

In the treatment of an intracranial aneurysm with the flow diverter, the combined use of coil embolization can help promote subsequent progressive thrombosis within the aneurysm sac and reduce the risk of delayed aneurysm rupture. This study retrospectively reviewed outcomes of patients who had undergone the Pipeline Embolization Device (PED) with adjunctive coil embolization (PED/coil) at a single center to determine its safety and efficiency. Patients with internal carotid artery aneurysms following an intradural component were selected for PED/coil between 2015 and 2020.

View Article and Find Full Text PDF

Background: Copolymer (Onyx) embolization is an effective treatment for dural arteriovenous fistula (dAVF), however, some dAVFs have multiple, high-flow feeding vessels, resulting in insufficient embolization. For the treatment of such patients, we have developed a novel flow-control technique, the 'damp-and-push technique'. The purpose of this study was to evaluate the technical efficiency and safety of this technique.

View Article and Find Full Text PDF

Objective: The efficacy and safety of acute percutaneous transluminal angioplasty or stenting (PTA/PTAS) for vertebrobasilar artery occlusion with atherothrombotic brain infarction (ATBI) have not been confirmed despite the resistance to medical therapy alone. There are few reports about this disease and its treatment. Therefore, the treatment outcomes at our hospital were summarized to evaluate the efficacy and safety.

View Article and Find Full Text PDF